KG
CPRX

Kilter Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Kilter Group’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33K Buy
106
+26
+33% +$767 ﹤0.01% 823
2026
Q1 		$1.98K Buy
80
+14
+21% +$334 ﹤0.01% 956
2025
Q4 		$1.54K Buy
66
+3
+5% +$67 ﹤0.01% 895
2025
Q3 		$1.24K Buy
63
+15
+31% +$308 ﹤0.01% 816
2025
Q2 		$1.04K Buy
+48
New +$1.13K ﹤0.01% 814

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kilter Group's CPRX Position: Q2 2026 in Review

Kilter Group increased its Catalyst Pharmaceutical (CPRX) stake by 33% in Q2 2026, buying an estimated $767 and bringing the position to 106 shares worth $3.33K. The position accounts for ﹤0.01% of the portfolio, ranked #823.

Kilter Group first reported a position in CPRX in Q2 2025 and has held it in 5 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Kilter Group held 106 shares of Catalyst Pharmaceutical worth $3.33K as of Q2 2026.
  • Kilter Group bought 26 Catalyst Pharmaceutical shares in Q2 2026, an estimated $767.
  • Catalyst Pharmaceutical made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #823 holding.
  • Kilter Group first reported a position in Catalyst Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.